Login

Johan Strid, CEO of Prevas AB, presentation at the 2021 annual meeting focused on strategic initiatives and company performance. 00:10:00

Share On Facebook Share On Twitter

Johan Strid is CEO of the Prevas

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
In-Depth Dialogue with Ray Dalio, Founder of Bridgewater Associates | Milken Institute Asia Summit 2024
00:10:00
PURSUING TRANSFORMATIONAL GROWTH AND IMPROVEMENT|Barry Siadat,MANAGING DIRECTOR,SK Capital Partners
00:10:00
Sfermion is NFT-focused fund with managing partners|Andrew Steinwold,Managing Partner,Sfermion
00:10:00
Las Chispas Project: Unveiling High-Grade Silver and Gold Opportunities in Sonora, Mexico
00:10:00
Sunshine Metals Confirms Liontown Feeder Zone with 17m @ 22.1 g/t Au Hit | Dr. Damien Keys, Managing Director, Sunshine Metals Ltd.
00:10:00
Leadership Journeys: Navigating Challenges and Charting Paths to Success | Derrick Msibi, CEO , STANLIB Wealth Management.
00:10:00
Success is rooted in gratitude, humility, generosity, and the effort to nurture relationships and teamwork.
00:10:00
Michel Vermette Discusses Armstrong Flooring's Strategic Rebuilding and Optimistic Outlook for 2021
00:10:00
Unlocking Opportunity: Nicole Hunter on Dimensional’s ETF Strategy | Nicole Hunter – Head of ETF Capital Markets, Dimensional Fund Advisors
00:10:00
Jane Sun, CEO of Trip.com, explores the transformative role of AI in shaping the future of the travel industry.
00:00:00
Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic
00:10:00
Charles Gordon, Head of Investor Relations at Hochschild Mining PLC provides insights into recent developments of the Peru-based gold and silver miner in the #OTCQX Video Series.|Eduardo Hochschild Chairman of Hochschild Mining PLC

© 2026 Nehu